In November 2014, the Institute of Health Economics partnered with Eli Lilly Canada Inc. and the Canadian Institutes of Health Research’s Institute for Health Services and Policy Research to hold a roundtable to discuss the federal role in healthcare innovation. The roundtable aimed to examine the existing state of healthcare innovation, its strengths and weaknesses (or gaps),…
The purpose of this roundtable was to gather a small, select group of thought leaders to engage in informed discourse, which was summarized in a report submitted to the new federal Healthcare Innovation Advisory Panel. This roundtable, created in response to the Federal Healthcare Innovation Advisory Panel’s call for stakeholder input, was an exciting opportunity to…
Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support…
Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…